Breast Cancer: Major Risk Factors and Recent Developments in Treatment

MiR-886-5p Inhibition Inhibits Growth and Induces Apoptosis of MCF7 Cells

(2014) Lei-Lei Zhang et al.   Asian Pacific Journal of Cancer Prevention

Fulvestrant 250mg versus Anastrozole 1 mg in the Treatment of Advanced Breast Cancer: a Meta-Analysis of Randomized Controlled Trials

(2014) Dan-Dan Gong et al.   Asian Pacific Journal of Cancer Prevention

Medical Treatment of Breast Cancer Bone Metastasis: From Bisphosphonates to Targeted Drugs

(2014) Bulent Erdogan et al.   Asian Pacific Journal of Cancer Prevention

in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangiferin in Doxorubicin-Treated MCF-7 Cells

(2014) Melva Louisa et al.   Asian Pacific Journal of Cancer Prevention

D-Pinitol Promotes Apoptosis in MCF-7 Cells via Induction of p53 and Bax and Inhibition of Bcl-2 and NF-κB

(2014) Thamaraiselvan Rengarajan et al.   Asian Pacific Journal of Cancer Prevention

Expert perspectives on biosimilar monoclonal antibodies in breast cancer

(2014) J. Cortés et al.   BREAST CANCER RESEARCH AND TREATMENT

Fulvestrant for advanced breast cancer: A meta-analysis

(2013) Mustafa Al-Mubarak et al.   CANCER TREATMENT REVIEWS

Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions

(2013) Adrian Bot et al.   Expert Review of Vaccines

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Current approaches and future directions in the treatment of HER2-positive breast cancer

(2012) Sara A. Hurvitz et al.   CANCER TREATMENT REVIEWS

New strategies for targeting the hypoxic tumour microenvironment in breast cancer

(2012) Carol Ward et al.   CANCER TREATMENT REVIEWS

A signature of immune function genes associated with recurrence-free survival in breast cancer patients

(2011) Maria Libera Ascierto et al.   BREAST CANCER RESEARCH AND TREATMENT

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

(2011) Meredith M Regan et al.   LANCET ONCOLOGY

Estrogen-Anchored pH-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer Therapy

(2011) Shivani R. Paliwal et al.   MOLECULAR PHARMACEUTICS

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool

(2010) Y H Chia et al.   BRITISH JOURNAL OF CANCER

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Adjuvant Hormonal Therapy for Early-Stage Breast Cancer

(2010) Harold J. Burstein et al.   Surgical Oncology Clinics of North America